LEVERAGED LONG CERTIFICATE - ESSILORLUXOTTICA Stock

Certificat

SLUX5L

DE000SH10Z18

Real-time Borsa Italiana 06:04:18 2024-05-20 am EDT
12.38 EUR -0.56% Intraday chart for LEVERAGED LONG CERTIFICATE - ESSILORLUXOTTICA
Current month+31.05%
1 month+25.25%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-20 12.38 -0.56%
24-05-17 12.45 +7.79%
24-05-16 11.55 -4.15%
24-05-15 12.05 +3.17%
24-05-14 11.68 0.00%

Real-time Borsa Italiana

Last update May 20, 2024 at 06:04 am EDT

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying ESSILORLUXOTTICA
IssuerLogo Issuer Société Générale Société Générale
SLUX5L
ISINDE000SH10Z18
Date issued 2022-01-26
Maturity Unlimited
Parity 1 : 1
Emission price 20
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 27.36
Lowest since issue 4.04
Spread 0.06
Spread %0.49%

Company Profile

EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, the company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux® and Transitions®, and world-class retail brands including Sunglass Hut and LensCrafters are part of the EssilorLuxottica family.
Sector
-
More about the company

Ratings for EssilorLuxottica

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: EssilorLuxottica

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
208.6 EUR
Average target price
205.9 EUR
Spread / Average Target
-1.30%
Consensus
  1. Stock Market
  2. Certificates
  3. SLUX5L Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW